In this issue:
Psoriasis prevalence in US adults
Hypochondriasis and personality traits in chronic plaque psoriasis
Infection and antibiotic exposure associated with paediatric psoriasis
Drug survival and predictors of discontinuation of methotrexate
Failure rates and survival times of systemic and biologic therapies
Dose adjustment of biologic treatments
Trimethylamine N-oxide and cardiovascular risk in psoriasis
Risankizumab for moderate-to-severe psoriasis
Serious GI-related adverse events with guselkumab
TNF inhibitors and COVID-19 risks
Please login below to download this issue (PDF)